Skip to main content
. 2023 Jan 10;13:1088557. doi: 10.3389/fendo.2022.1088557

Table 4.

MR results and sensitivity analyses between steroid hormones and AMD in the discovery stage.

P (MR results) P (Cochrane's Q) P (Pleiotropy)
IVW MR-Egger WM MLE MR-RAPS IVW MR-Egger MR-Egger regression MR-PRESSO
Aldo 0.39 0.71 0.58 0.64 0.65 0.89 0.89 0.46 0.920
A4 0.79 0.59 0.79 0.52 0.53 0.38 0.33 0.63 0.271
P4 0.82 0.70 0.45 0.94 0.94 0.18 0.15 0.74 0.196
17-OHP 0.43 0.21 0.74 0.73 0.74 0.51 0.54 0.29 0.564
T/E2 0.75 0.78 0.81 0.68 0.68 0.07 0.06 0.67 0.066

MR, Mendelian randomization; IVW, Inverse variance weighted; WM, Weighted median; MLE, maximum likelihood estimator; MR-RAPS, MR robust adjusted profile score; Aldo, aldosterone; A4, androstenedione; P4, progesterone; 17-OHP, hydroxyprogesterone; T/E, Testosterone_Estradiol_Ratio.